Long-acting Injectables: Microsphere Design, Development and Scale-up Using Lactide/Glycolide-Based Polymers, Upcoming Webinar Hosted by Xtalks

Published on

A laptop is open on a table with a mug next to it and a notepad with pen in front of it.

XTalks have announced a free webinar on long-acting injectables. Learn about the selection and optimization of long-acting microsphere formulations with releases ranging from weeks to one year. Attendees will learn about the critical quality attributes that can help achieve tunable release profiles in long-acting drug formulations.

The featured speakers will discuss the development and scale-up challenges that can be approached and overcome. The speakers will also share strategies in microsphere technology that can be coupled with appropriate bioresorbable polymers.

In this webinar, the speakers will showcase the selection and optimization of long-acting microsphere formulations with releases ranging from weeks to one year.

The speakers will discuss the chemistry of lactide/glycolide-based bioresorbable polymers applied to various parenteral formulations and a microsphere technology platform that offers reproducible, scalable and consistent critical quality attributes under current good manufacturing practices (cGMP) for multiple therapeutic indications.

They will explain the chemistry, key characteristics and versatility of lactide/glycolide polymers and show how challenges in controlled drug release formulations and medical devices can be solved. They will also detail the advantages of ultra-low residual monomer specifications.

The speakers will also present two microsphere case studies: (1) a peptide formulation development with varied release needs and (2) a small molecule active pharmaceutical ingredient (API) from formulation development through scale-up, highlighting common scale-up challenges and solutions. These case studies showcase how varying process parameters and polymer chemistries based on lactide and glycolide make it possible to optimize drug load, release duration, particle size and encapsulation efficiency.

Register for this webinar on long-acting injectables to learn about the selection and optimization of long-acting microsphere formulations with releases ranging from weeks to one year.

Join Patrick Duffy, R&D Team Leader, Ashland; and Rachel Minrovic, R&D – Formulations, Oakwood Laboratories, for the live webinar on Tuesday, January 21, 2025, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Long-acting Injectables: Microsphere Design, Development and Scale-up Using Lactide/Glycolide-Based Polymers.

For more information, read the original press release.

For more news from the world of long-acting therapeutics, sign up to the CELT's LONGEVITY mailing list here for regular updates.